Cargando…
Friend or Foe: Prognostic and Immunotherapy Roles of BTLA in Colorectal Cancer
BACKGROUND: B and T lymphocyte attenuator (BTLA) is a co-signaling protein belonging to the CD28 immunoglobulin superfamily. However, the role of BTLA in prognosis and immunotherapy of colorectal cancer (CRC) remains unclear. METHODS: We evaluated the expression of BTLA via the Oncomine and the canc...
Autores principales: | Song, Jingjing, Wu, Lihui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7385242/ https://www.ncbi.nlm.nih.gov/pubmed/32793631 http://dx.doi.org/10.3389/fmolb.2020.00148 |
Ejemplares similares
-
Editorial: Function and Flexibility: Friend or Foe?
por: Pauwels, Kris, et al.
Publicado: (2016) -
Editorial: TGF-β signalling pathways and their enigmatic role as a friend and foe in human health and diseases
por: Betapudi, Venkaiah, et al.
Publicado: (2023) -
Role of TFRC as a Novel Prognostic Biomarker and in Immunotherapy for Pancreatic Carcinoma
por: Yang, Cheng, et al.
Publicado: (2022) -
Prognostic Value and Immunological Role of KIFC1 in Hepatocellular Carcinoma
por: Li, Dan, et al.
Publicado: (2022) -
Ferroptosis: friend or foe in cancer immunotherapy?
por: Demuynck, Robin, et al.
Publicado: (2023)